BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19900757)

  • 1. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.
    Yu J; Lan J; Wang C; Wu Q; Zhu Y; Lai X; Sun J; Jin C; Huang H
    Cancer Lett; 2010 May; 291(2):177-86. PubMed ID: 19900757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
    Chung I; Leonhardt H; Rippe K
    J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
    Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
    J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
    Jiang WQ; Zhong ZH; Henson JD; Reddel RR
    Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
    Wu G; Jiang X; Lee WH; Chen PL
    Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The F-box protein β-TrCP promotes ubiquitination of TRF1 and regulates the ALT-associated PML bodies formation in U2OS cells.
    Wang C; Xiao H; Ma J; Zhu Y; Yu J; Sun L; Sun H; Liu Y; Jin C; Huang H
    Biochem Biophys Res Commun; 2013 May; 434(4):728-34. PubMed ID: 23583392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
    Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
    Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
    Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk-dependent phosphorylation regulates TRF1 recruitment to PML bodies and promotes C-circle production in ALT cells.
    Wilson FR; Ho A; Walker JR; Zhu XD
    J Cell Sci; 2016 Jul; 129(13):2559-72. PubMed ID: 27185864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
    Ho A; Wilson FR; Peragine SL; Jeyanthan K; Mitchell TR; Zhu XD
    Sci Rep; 2016 Nov; 6():36913. PubMed ID: 27841304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML3 Orchestrates the Nuclear Dynamics and Function of TIP60.
    Wu Q; Hu H; Lan J; Emenari C; Wang Z; Chang KS; Huang H; Yao X
    J Biol Chem; 2009 Mar; 284(13):8747-59. PubMed ID: 19150978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeric DNA mediates de novo PML body formation.
    Brouwer AK; Schimmel J; Wiegant JC; Vertegaal AC; Tanke HJ; Dirks RW
    Mol Biol Cell; 2009 Nov; 20(22):4804-15. PubMed ID: 19793919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
    Yeager TR; Neumann AA; Englezou A; Huschtscha LI; Noble JR; Reddel RR
    Cancer Res; 1999 Sep; 59(17):4175-9. PubMed ID: 10485449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.
    Stagno D'Alcontres M; Mendez-Bermudez A; Foxon JL; Royle NJ; Salomoni P
    J Cell Biol; 2007 Dec; 179(5):855-67. PubMed ID: 18056407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.
    French JD; Dunn J; Smart CE; Manning N; Brown MA
    Genes Chromosomes Cancer; 2006 Mar; 45(3):277-89. PubMed ID: 16283620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells.
    Shen H; Maki CG
    J Cell Biochem; 2010 Dec; 111(5):1280-90. PubMed ID: 20803550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
    Grobelny JV; Godwin AK; Broccoli D
    J Cell Sci; 2000 Dec; 113 Pt 24():4577-85. PubMed ID: 11082050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human PinX1 mediates TRF1 accumulation in nucleolus and enhances TRF1 binding to telomeres.
    Yoo JE; Oh BK; Park YN
    J Mol Biol; 2009 May; 388(5):928-40. PubMed ID: 19265708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleostemin prevents telomere damage by promoting PML-IV recruitment to SUMOylated TRF1.
    Hsu JK; Lin T; Tsai RY
    J Cell Biol; 2012 May; 197(5):613-24. PubMed ID: 22641345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.